S5SG:F:F-UBS (Irl) ETF plc - S&P 500 ESG UCITS ETF Hedged to EUR A Acc (EUR)

ETF | Others |

Last Closing

USD 31.395

Change

-0.03 (-0.08)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.20 (+0.04%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.54 (+1.07%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.86 (+1.54%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.32 (+2.16%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.33%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+3.06 (+3.33%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.50 (+1.10%)

USD 45.80B
0ZC:F Zscaler Inc

+3.55 (+1.74%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing S5SG:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.89% 35% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.89% 35% F 47% F
Trailing 12 Months  
Capital Gain 7.02% 73% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.02% 70% C- 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.74% 62% D 61% D-
Dividend Return 7.74% 59% D- 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.46% 58% F 88% B+
Risk Adjusted Return 67.48% 68% D+ 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike